Welcome to the European Association for Cancer Research
Connecting cancer researchers together
Signalling Circuits in Cancer
Virtual Event : 10 - 11 February 2026
Scientific programme
To download and print the programme, use the links below.
Listed times are in Central European Time (CET)
WELCOME TO DAY ONE
Session 1
Session Chair: Chiara Ambrogio
Andreas Trumpp HI-STEM, Germany
'From LSCs to neurons in Pancreatic Cancer'
Q&A 12:25-12:35
Janne Lehtiö Karolinska Institut, Sweden
'Proteogenomics for systems level analysis of genotype - molecular phenotype connections in cancer'
Q&A 12:55-13:05
Proffered Paper 1
Q&A 13:15-13:20
Proffered Paper 2
Q&A 13:30-13:35
REFRESHMENT BREAK
Session 2
Session Chair: Jukka Westermarck
Flash Talks Session 1
4 top-scoring abstracts presented as 3-minute flash talks
Zuzana Storchová RPTU, Germany
'Aneuploidy-driven stress responses in cancer cells'
Q&A 14:25-14:35
Proffered Paper 3
Q&A 14:45-14:50
REFRESHMENT BREAK
Flash Talks Session 2
4 top-scoring abstracts presented as 3-minute flash talks
Proffered Paper 4
Q&A 15:30-15:35
Proffered Paper 5
Q&A 15:45-15:50
Arjun Raj Perelman School of Medicine, USA
'Cell states that drive therapy resistance and oncogenesis'
Q&A 16:15-16:30
SUMMARY AND CLOSE
Listed times are in Central European Time (CET)
WELCOME TO DAY TWO
Session 3
Session Chair: Yaara Oren
Stephan Vagner Institut Curie, France
'The RNA binding activity of the BRAF kinase'
Q&A 12:25-12:35
Adrian Saurin University of Dundee, UK
'Understanding resistance to cell cycle-based chemotherapies'
Q&A 12:55-13:05
Proffered Paper 6
Q&A 13:15-13:20
Proffered Paper 7
Q&A 13:30-13:35
REFRESHMENT BREAK
Session 4
Session Chair: Venkatram Yellapragada
Flash Talks Session 4
4 top-scoring abstracts presented as 3-minute flash talks
Proffered Paper 8
Q&A 14:15-14:20
Lior Lobel Bar-Ilan University, Israel
'Gut Microbial Activity Modulates Cancer Immunotherapy'
Q&A 14:40-14:50
REFRESHMENT BREAK
Flash Talks Session 4
4 top-scoring abstracts presented as 3-minute flash talks
Melissa Junttila ORIC Pharmaceuticals Inc, USA
'PRC2 inhibition enhances sensitivity to androgen receptor pathway inhibitors by restricting adaptation of prostate tumors and inducing a luminal cell state'
Q&A 15:40-15:50
Proffered Paper 9
Q&A 16:00-16:05
DISCUSSION SESSION
Open Forum with SPC members Jukka Westermarck, Yaara Oren and Chiara Ambrogio
SUMMARY AND CLOSE
Key dates
Abstract submission deadline:
15 December 2025
Registration and Payment deadline:
19 January 2026
